We recently published a list of 10 Stocks Grow Firmer Despite Mixed Market Sentiment. In this article, we are going to take a look at where Baxter International Inc. (NYSE:BAX) stands against other stocks that grow firmer despite mixed market sentiment.

The stock market kicked off the first trading day of the week on a lackluster note, with major indices finishing mixed as it struggled to rebound from Friday’s bloodbath.

The Dow Jones was the sole gainer among the main indices, eking out a 0.08-percent gain. In contrast, the S&P 500 and the tech-heavy Nasdaq both fell 0.50 percent and 1.21 percent, respectively.

Meanwhile, ten companies registered strength, albeit posting only modest gains. This article details the reasons behind their performance.

To come up with Monday’s top gainers, we considered only the stocks with $2 billion in market capitalization and $5 million in daily trading volume.

Patients connected to dialysis machines in a hospital ward, highlighting the company's dialysis and intravenous therapies.

Baxter International Inc. (NYSE:BAX)

Baxter International grew its share prices by 3.73 percent on Monday to close at $35.08 apiece as investor sentiment was buoyed by an investment bank’s upgraded rating for the company.

In a report, UBS raised its price target for BAX by 7.7 percent to $35 from $32.5 previously, while maintaining a ‘neutral’ rating for the company.

The rating adjustment followed the company’s release of its 2024 earnings, where it swung to a net loss attributable to shareholders of $512 million in the last quarter versus the $245 million attributable net income registered in the same period a year earlier.

Net sales were little changed, up only 1 percent to $2.753 billion from $2.729 billion in the same comparable period.

In the full year alone, BAX also registered a net loss attributable to shareholders of $649 million, a reversal from the $2.656 billion attributable net income in 2023.

Overall, BAX ranks 9th on our list of stocks that grow firmer despite mixed market sentiment. While we acknowledge the potential of BAX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is as promising as BAX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.